当前位置:
X-MOL 学术
›
Alzheimers Dement.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A near-infrared probe for detecting and interposing amyloid beta oligomerization in early Alzheimer's disease
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2022-04-18 , DOI: 10.1002/alz.12673 Li Quan 1, 2 , Ines Moreno-Gonzalez 3, 4, 5 , Zhigang Xie 6 , Nazaret Gamez 3, 4 , Laura Vegas-Gomez 4 , Qinyong Song 1 , Jianhua Gu 7 , Wenhai Lin 6 , Ruben Gomez-Gutierrez 3, 4 , Tianfu Wu 2
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2022-04-18 , DOI: 10.1002/alz.12673 Li Quan 1, 2 , Ines Moreno-Gonzalez 3, 4, 5 , Zhigang Xie 6 , Nazaret Gamez 3, 4 , Laura Vegas-Gomez 4 , Qinyong Song 1 , Jianhua Gu 7 , Wenhai Lin 6 , Ruben Gomez-Gutierrez 3, 4 , Tianfu Wu 2
Affiliation
The misfolding and deposition of amyloid beta (Aβ) in human brain is the main hallmark of Alzheimer's disease (AD) pathology. One of the drivers of Alzheimer´s pathogenesis is the production of soluble oligomeric Aβ, which could potentially serve as a biomarker of AD.
中文翻译:
用于检测和干预早期阿尔茨海默病中淀粉样蛋白 β 寡聚化的近红外探针
人脑中淀粉样蛋白 (Aβ) 的错误折叠和沉积是阿尔茨海默病 (AD) 病理学的主要标志。阿尔茨海默病发病机制的驱动因素之一是可溶性寡聚 Aβ 的产生,它有可能作为 AD 的生物标志物。
更新日期:2022-04-18
中文翻译:
用于检测和干预早期阿尔茨海默病中淀粉样蛋白 β 寡聚化的近红外探针
人脑中淀粉样蛋白 (Aβ) 的错误折叠和沉积是阿尔茨海默病 (AD) 病理学的主要标志。阿尔茨海默病发病机制的驱动因素之一是可溶性寡聚 Aβ 的产生,它有可能作为 AD 的生物标志物。